[{"ID":"23212_33-2022_NCT01145612","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have Marfan syndrome?\n\nYes, the patient has Marfan syndrome, as confirmed by the Ghent criteria.\n\n#2: Is the patient male or female?\n\nThe patient is male.\n\n#3: Is the patient within the age range of 5-60 years?\n\nYes, the patient is within the age range of 5-60 years.\n\n#4: Is the patient able to take oral medication?\n\nYes, the patient is able to take oral medication.\n\n#5: Is the patient willing to avoid pregnancy for four weeks prior to, during, and three months after the last dose of study medication?\n\nNo, the patient is not willing to avoid pregnancy, as he is male and does not have the potential to become pregnant.\n\n#6: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9374900766},{"ID":"35733_75-2021_NCT04054960","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Idiopathic Parkinson's disease (IPD)?\nYes, the patient has Parkinson's disease, which is a type of IPD.\n\n#2: Does the patient have any of the exclusion criteria?\nNo, the patient does not have any of the exclusion criteria (Parkinson plus syndromes, drug-induced parkinsonism, or inability to provide informed consent).\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9110184813},{"ID":"6765_15-2021_NCT01897623","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient male?\nNo, the patient is a 70-year-old woman.\n\n#2: Does the patient have coronary artery disease?\nYes, the patient has a history of CAD.\n\n#3: Is the patient willing to participate?\nNo, the patient is not eligible for the clinical trial because she is a female and the trial is only for male patients with CAD.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.901155592},{"ID":"30872_65-2021_NCT03660293","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have type 1 diabetes?\nYes, the patient has type 1 diabetes.\n\n#2: Is the patient a child or adolescent?\nNo, the patient is a 25-year-old man, so he is not a child or adolescent.\n\n#3: Has the patient had type 1 diabetes for at least 3 years?\nNo, the patient was diagnosed with type 1 diabetes 7 years ago, so he has not had the disease for at least 3 years.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9299355585},{"ID":"30672_65-2021_NCT01883024","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria:\n\n* Men and women \u2265 18 years of age: Yes (25 years old)\n* Patients with type 1 diabetes for more than 2 years: Yes (diagnosed 7 years ago)\n* Patients treated by insulin pump for more than 6 months: Yes (not specified, but the patient is taking insulin pump)\n* Patients using of real-time continuous glucose monitoring for more than 3 months: Yes (not specified, but the patient is using continuous glucose monitoring)\n\n#2: Does the patient meet the exclusion criteria?\n\nNo, the patient does not meet the exclusion criteria:\n\n* Pregnancy or breastfeeding: No\n* Current infectious disease: No\n* Adults legally protected (under judicial protection, guardianship, or supervision): No\n* Persons deprived of their liberty: No\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9481575983},{"ID":"14217_30-2021_NCT03862755","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient a lung surgical patient?\nNo, the patient is not a lung surgical patient.\n\n#2: Did the patient stay in the thoracic postoperative ICU ward for at least 24 hours?\nNo, the patient did not stay in the ICU ward.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.8991434106},{"ID":"33415_71-2021_NCT00362908","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have metabolic syndrome?\n\nYes, the patient has metabolic syndrome because she has at least three of the following five criteria:\n\n* Abdominal obesity (greater than 90 cm in Asian women)\n* Triglycerides (greater than or equal to 150 mg\/dL)\n* HDL cholesterol levels (less than 50 mg\/dL in women)\n* Blood pressure levels (greater than 130\/85 mmHg)\n* Fasting glucose (greater than or equal to 100 mg\/dL)\n\n#2: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria. She does not have a history of coronary disease, she is not taking any lipid-lowering medication, she is not taking high doses of thiazide diuretics, she is not using any fish oil supplements, and she does not have any unstable medical conditions.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9354948348},{"ID":"35670_75-2021_NCT03587168","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient at least 40 years old?\n\nYes, the patient is 55 years old, which is greater than 40.\n\n#2: Does the patient have a neurologist-diagnosed Parkinson's disease?\n\nYes, the patient has a neurologist-diagnosed Parkinson's disease.\n\n#3: Is the patient's Hoehn-Yahr stage 1 to 4?\n\nYes, the patient's Hoehn-Yahr stage is I, which is within the range of 1 to 4.\n\n#4: Is the patient able to walk 10 meters with or without aids?\n\nYes, the patient is able to walk 10 meters with or without aids.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9321108659},{"ID":"35793_75-2021_NCT04512599","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nA: Yes, the patient has been clinically diagnosed with Parkinson's disease.\n\n#2: Is the patient over the age of 30?\n\nA: Yes, the patient is 55 years old, which is over the age of 30.\n\n#3: Is the patient able to consent?\n\nA: Yes, the patient is alert and cooperative, and does not have any signs of dementia.\n\n#4: Does the patient have any of the exclusion criteria?\n\nB: No, the patient does not have any of the exclusion criteria, such as prior intestinal resection, history of GI diseases, severe renal disease, markedly abnormal liver function, or recent antibiotic use.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9319986856},{"ID":"17190_36-2021_NCT02751307","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have schizophrenia or schizoaffective disorder?\nNo, the patient does not have schizophrenia or schizoaffective disorder.\n\n#2: Is the patient aged 20-65 years?\nNo, the patient is 32 years old, which is outside the age range of 20-65 years.\n\n#3: Has the patient taken clozapine for at least 3 months?\nNo, the patient has not taken clozapine.\n\n#4: Does the patient have at least one of the following metabolic abnormalities?\nNo, the patient does not have any of the specified metabolic abnormalities.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.946017717},{"ID":"5511_12-2021_NCT04038879","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the age requirement?\nYes, the patient is 34 years old, which is greater than or equal to 18 years old, the minimum age requirement for the clinical trial.\n\n#2: Is the patient able to give informed consent?\nYes, the patient is able to give informed consent, as they are conscious and aware of the clinical trial and its potential risks and benefits.\n\n#3: Does the patient have a known condition that would make them ineligible for the clinical trial?\nYes, the patient has Marfan's syndrome, which is a known condition that would make them ineligible for the clinical trial. The clinical trial excludes patients with known intracardiac shunt, which is a characteristic of Marfan's syndrome.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9124535685},{"ID":"13969_30-2021_NCT00566280","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of bloody nipple discharge?\nNo, the patient does not have a history of bloody nipple discharge.\n\n#2: Does the patient have a negative diagnostic mammogram and ultrasound?\nNo, the patient does not have a negative diagnostic mammogram and ultrasound.\n\n#3: Is the patient a woman aged 25-75?\nYes, the patient is a woman aged 33, which is within the inclusion criteria of 25-75.\n\n#4: Is the patient physically able to sit upright and still for 40 minutes?\nYes, the patient is physically able to sit upright and still for 40 minutes.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9362269686},{"ID":"5314_12-2021_NCT01694251","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a scheduled elective mitral valve repair surgery?\nYes, the patient is scheduled to undergo elective mitral valve repair surgery.\n\n#2: Does the patient have more than moderate mitral stenosis?\nYes, the patient has severe mitral stenosis.\n\n#3: Does the patient have left atrial enlargement?\nYes, the patient has left atrial enlargement.\n\n#4: Is the patient at least 18 years old?\nYes, the patient is 34 years old and meets the age requirement.\n\n#5: Does the patient have reduced left or right ventricular function (ejection fraction < 40%)?\nNo, the patient does not have reduced left or right ventricular function.\n\n#6: Does the patient have mitral regurgitation grade more than moderate?\nYes, the patient has mitral regurgitation grade more than moderate.\n\n#7: Is the patient scheduled for repeated surgery for cardiac valvular disease?\nNo, the patient is not scheduled for repeated surgery for cardiac valvular disease.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9474148707},{"ID":"14150_30-2021_NCT03103776","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria because she is over 18 years old and has been referred to the ENT service of the CHU of Amiens for thyroidectomy in the context of Hashimoto's thyroiditis.\n\n#2: Does the patient meet any of the exclusion criteria?\n\nNo, the patient does not meet any of the exclusion criteria because she is not a minor, is not under tutorship or curatorship.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9206831568},{"ID":"17155_36-2021_NCT02542735","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient part of the general population?\nYes, the patient is part of the general population.\n\n#2: Does the patient have diabetes in cross-sectional study?\nNo, the patient does not have diabetes in cross-sectional study.\n\n#3: Does the patient have any other disabling situation that prevents participation?\nNo, the patient does not have any other disabling situation that prevents participation.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9371650047},{"ID":"30414_65-2021_NCT00206258","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have diabetes?\nYes, the patient has type 1 diabetes.\n\n#2: Is the patient's age within the inclusion criteria (12-18 years old)?\nNo, the patient is 25 years old, which is outside of the inclusion criteria.\n\n#3: Is the patient's HbA1c level within the inclusion criteria (<8%)?\nNo, the patient's HbA1c level is 6.5%, which is within the normal range but not within the inclusion criteria.\n\n#4: Is the patient otherwise healthy except for their diabetes?\nYes, the patient is otherwise healthy.\n\n#5: Does the patient meet any of the exclusion criteria?\nNo, the patient does not meet any of the exclusion criteria.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9267353081},{"ID":"33492_71-2021_NCT00974831","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a fasting blood glucose level of \u2265 70mg\/dL and \u2264 125 mg\/dL?\n\nNo, the patient's fasting blood glucose level is 98 mg\/dL, which is outside the range of 70-125 mg\/dL. Therefore, the patient does not meet this inclusion criterion.\n\n#2: Does the patient state that they do not have type 1 or 2 diabetes?\n\nYes, the patient does not have type 1 or 2 diabetes, so this criterion is met.\n\n#3: Is the patient overweight as defined by waist circumference \u2265 101 cm (40 inches) male; \u2265 88 cm (35 inches) female?\n\nYes, the patient is overweight based on the waist circumference criterion.\n\n#4: Does the patient have a BMI of \u2265 25 kg\/m2?\n\nYes, the patient has a BMI of 41.54, which meets this criterion.\n\n#5: Is the patient's blood pressure < 140 mm Hg systolic and < 90 mm Hg diastolic?\n\nYes, the patient's blood pressure is within the normal range.\n\n#6: Is the patient between 20 and 45 years of age, inclusive?\n\nYes, the patient is between 20 and 45 years of age.\n\n#7: Is the patient a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum prior to screening visit?\n\nYes, the patient is a non-pregnant, non-lactating female.\n\n#8: If female is of childbearing potential, is practicing birth control?\n\nNo, the patient is not practicing birth control.\n\n#9: If subject is on a chronic medication such as a thyroid medication or hormone therapy, has been on constant dosage for at least two months prior to screening visit.\n\nNo, the patient is not on any chronic medication.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9636218933},{"ID":"30568_65-2021_NCT01314586","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the age criteria?\n\nYes, the patient is between 40-65 years old, which meets the age criteria.\n\n#2: Does the patient meet the gender criteria?\n\nNo, the patient is a male, and the clinical trial only includes men and postmenopausal women.\n\n#3: Does the patient have hypercholesterolemia?\n\nYes, the patient has hypercholesterolemia, as evidenced by their high cholesterol levels (total cholesterol >240 mg\/dl and LDL cholesterol >140 mg\/dl).\n\n#4: Is the patient taking any excluded medications or supplements?\n\nYes, the patient is taking ACE inhibitors, which are excluded from the clinical trial.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9362450212},{"ID":"17383_36-2021_NCT04297553","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have PCOS?\n\nYes, the patient has PCOS, so we can proceed to the next question.\n\n#2: Does the patient have high AFC (\u226524 Antral Follicles in Both Ovaries)?\n\nNo, the patient does not have high AFC. The patient has a BMI of 41.54, which is outside the normal range, but this is not a criterion for the clinical trial.\n\n#3: Is the patient having indications for ART?\n\nNo, the patient is not having indications for ART. The patient is complaining of sleep apnea and dissatisfaction with her body shape, but these are not indications for ART.\n\n#4: Is the patient a permanent resident of Vietnam?\n\nNo, the patient is not a permanent resident of Vietnam.\n\n#5: Is the patient agreeable to have fresh embryos transfer or freeze-only on day 3?\n\nNo, the patient is not agreeable to have fresh embryos transfer or freeze-only on day 3. The patient is not undergoing ART.\n\n#6: Is the patient agreeable to have \u2264 2 embryos transferred?\n\nNo, the patient is not agreeable to have \u2264 2 embryos transferred. The patient is not undergoing ART.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.935036831},{"ID":"28014_40-2022_NCT04053699","TOPIC_YEAR":2022,"RESPONSE":"#1: Is the patient male or female?\n\nB: excluded","PROBA":0.7357272001},{"ID":"30892_65-2021_NCT03887364","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have any facial injury or surgery?\nNo, the patient does not have any facial injury or surgery, so the exclusion criterion is not met.\n\n#2: Does the patient have sinusitis?\nNo, the patient does not have sinusitis, so the exclusion criterion is not met.\n\n#3: Does the patient have respiratory failure?\nNo, the patient does not have respiratory failure, so the exclusion criterion is not met.\n\n#4: Does the patient have dyspnea on cardiac origin?\nYes, the patient has dyspnea on cardiac origin, so the patient is not eligible for the clinical trial.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9410136639},{"ID":"7000_15-2021_NCT03955081","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient of child-bearing age?\nNo, the patient is 70 years old.\n\n#2: Is the patient currently pregnant or planning to become pregnant within the study period?\nNo, the patient is not pregnant.\n\n#3: Does the patient have any contraindication to standard enteroscopy?\nNo, the patient does not have any contraindication to standard enteroscopy.\n\n#4: Is the patient concurrently participating in another competing clinical study?\nNo, the patient is not concurrently participating in another competing clinical study.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9334999163},{"ID":"17017_36-2021_NCT01312090","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a BMI > 30?\n\nYes, the patient has a BMI of 41.54, which is well above the threshold of 30.\n\n#2: Is the patient's body weight less than 120 kg?\n\nNo, the patient weighs 113 kg, which is above the threshold of 120 kg.\n\n#3: Has the patient had weight stability for 3 months?\n\nNo, the patient has not had weight stability for 3 months.\n\n#4: Are the patient's plasma triglyceride concentration and HDL-cholesterol within the specified ranges?\n\nNo, the patient's plasma triglyceride concentration is 150 mg\/dl, which is above the threshold of 3.0 mmol\/l. The patient's HDL-cholesterol is 35 mg\/dl, which is below the threshold of 0.9 mmol\/l in females.\n\n#5: Does the patient have normal blood pressure?\n\nNo, the patient's blood pressure is 130\/80 mmHg, which is above the threshold of 140\/90 mmHg.\n\n#6: Does the patient have normal glucose tolerance?\n\nNo, the patient has impaired glucose tolerance (IGT) with a fasting glucose of 98 mg\/dl and a 2-hour glucose of 145 mg\/dl.\n\nBased on these criteria, the patient is not eligible for the clinical trial.","PROBA":0.9527505435},{"ID":"17015_36-2021_NCT01275235","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient a sibling of someone who was exposed to diabetes in the womb?\nNo, the patient is not a sibling of someone who was exposed to diabetes in the womb.\n\n#2: Is the patient between the ages of 20 and 34 years (inclusive)?\nYes, the patient is 32 years old, which is within the age range of 20 to 34 years.\n\n#3: Is the patient's body mass index (BMI) between 20 and 29 Kg\/m2 inclusive?\nNo, the patient's BMI is 41.54, which is above the upper limit of 29 Kg\/m2.\n\n#4: Is the patient healthy as assessed by medical history and standard physical examination?\nNo, the patient has a high BMI and is complaining of sleep apnea, PCO, and dissatisfaction with her body shape, which suggests that she may have health issues.\n\n#5: Is the patient willing to stay overnight one time at the Pennington Center?\nNo, the patient does not meet this criterion.\n\n#6: Does the patient have low physical activity (< 100 min of exercise per week)?\nYes, the patient completed the four square step test in 14 seconds, which suggests that she has low physical activity.\n\nBased on the criteria for the clinical trial, the patient is not eligible for the study.","PROBA":0.9433713296},{"ID":"33798_71-2021_NCT03367728","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria because they are undergoing Roux-en-Y gastric bypass surgery.\n\n#2: Does the patient meet any of the exclusion criteria?\n\nNo, the patient does not meet any of the exclusion criteria.","PROBA":0.8846679602},{"ID":"27884_40-2022_NCT03232177","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have essential thrombocythemia?\n\nNo, the patient does not have essential thrombocythemia. The patient has prolonged oral bleeding after a tooth extraction, which is not a symptom of essential thrombocythemia.\n\n#2: Does the patient meet any of the high-risk criteria?\n\nNo, the patient does not meet any of the high-risk criteria for essential thrombocythemia. The patient does not have a history of thromboembolic bleeding, and there is no mention of hypertension, diabetes, or past history of thromboembolic bleeding.\n\n#3: Is the patient taking any medications that would make them ineligible for the clinical trial?\n\nNo, the patient is not taking any medications that would make them ineligible for the clinical trial.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9396658745},{"ID":"6703_15-2021_NCT01360918","TOPIC_YEAR":2021,"RESPONSE":"#1: Patients \u2265 18 years of age\n\nEligible\n\n#2: Documented history of paroxysmal, persistent, longstanding persistent or newly-diagnosed AF prior to admittance for cardiac surgery\n\nEligible\n\n#3: Patients will have elective coronary surgery planned\n\nEligible\n\n#4: Patients \u226570 years of age\n\nIneligible\n\n#5: Pregnancy\n\nNot applicable\n\n#6: Patients undergoing emergency operation\n\nNot applicable\n\n#7: Patients undergoing concomitant valve replacement\n\nIneligible\n\n#8: Severely enlarged LA (>50 mm) on echocardiography\n\nNot applicable\n\n#9: Prior AF ablation or AF surgery\n\nNot applicable\n\nBased on the provided information, the patient is ineligible for the clinical trial since she is over the age of 70.","PROBA":0.9402298465},{"ID":"6670_15-2021_NCT01050361","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 70 years old, which is greater than or equal to 65 years old, the minimum age requirement for the clinical trial. Therefore, the patient meets the age inclusion criterion.\n\n#2: Hypertension\nThe patient has a history of hypertension, which meets the inclusion criterion #2.\n\n#3: Diabetes\nThere is no mention of diabetes in the patient's history, so the patient does not meet the inclusion criterion #3.\n\n#4: Obesity\nThere is no mention of obesity in the patient's history, so the patient does not meet the inclusion criterion #4.\n\n#5: Renal insufficiency\nThe patient has a history of chronic kidney disease (CKD), which meets the inclusion criterion #5.\n\n#6: Tobacco usage\nThere is no mention of tobacco usage in the patient's history, so the patient does not meet the inclusion criterion #6.\n\n#7: Hypercholesterolemia\nThere is no mention of hypercholesterolemia in the patient's history, so the patient does not meet the inclusion criterion #7.\n\n#8: Sleep apnea\/heavy snoring at night\nThere is no mention of sleep apnea or heavy snoring in the patient's history, so the patient does not meet the inclusion criterion #8.\n\n#9: Clinical diagnosis of CHF\nThe patient has a history of coronary artery disease (CAD) and a recent diagnosis of pancreatic adenocarcinoma, but there is no mention of a clinical diagnosis of congestive heart failure (CHF). Therefore, the patient does not meet the inclusion criterion #9.\n\nBased on the patient's history, the patient does not meet the inclusion criteria for the clinical trial. Therefore, the patient is not eligible for the clinical trial.","PROBA":0.9630589476},{"ID":"35532_75-2021_NCT02304848","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have idiopathic Parkinson's disease?\nYes, the patient has a diagnosis of Parkinson's disease.\n\n#2: Is the patient at Hoehn and Yahr Stage I?\nNo, the patient is at Hoehn and Yahr Stage I, which is not eligible for the clinical trial. The clinical trial requires patients to be at Hoehn and Yahr Stage II or higher.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9267334492},{"ID":"24997_53-2021_NCT00750477","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have known symptomatic osteoarthritis of the knee?\nNo, the patient does not have known symptomatic osteoarthritis of the knee.\n\n#2: Does the patient have persistent knee pain associated with osteoarthritis with a baseline score of at least 30 mm on the Patient's Assessment of Arthritis Pain - Visual Analog Scale?\nNo, the patient does not have persistent knee pain associated with osteoarthritis.\n\n#3: Is the patient currently taking any pain relief medications?\nNo, the patient is not currently taking any pain relief medications.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9509956984},{"ID":"33581_71-2021_NCT01675713","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria of being morbidly obese, as her BMI is 41.5.\n\n#2: Does the patient meet any of the exclusion criteria?\n\nNo, the patient does not meet any of the exclusion criteria, as she is able to walk slowly for 20 minutes.","PROBA":0.8959306103},{"ID":"13959_30-2021_NCT00493103","TOPIC_YEAR":2021,"RESPONSE":"$}}%C: irrelevant%\">C: irrelevant","PROBA":0.5612121562},{"ID":"17294_36-2021_NCT03514667","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a body mass index (BMI) of 25 or greater?\n\nYes, the patient has a BMI of 41.54, which is well above the threshold of 25.\n\n#2: Does the patient have waist circumference of greater than 102 cm in men or 88 cm in women?\n\nYes, the patient has a waist circumference of 113 cm, which is greater than the threshold for women (88 cm).\n\n#3: Does the patient have fasting blood glucose of greater than 100 mg\/dL?\n\nNo, the patient's fasting blood glucose is not specified in the patient note.\n\n#4: Does the patient have triglycerides (TG) of greater than 150 mg\/dL?\n\nYes, the patient has a TG of 150 mg\/dL, which is greater than the threshold.\n\n#5: Is the patient's HDL-C less than 50 in women or less than 40 in men?\n\nYes, the patient's HDL-C is less than 40 in men (35 mg\/dL).\n\n#6: Does the patient have a systolic blood pressure (SBP) of greater than 130 mmHg or diastolic blood pressure (DBP) of greater than 85 mmHg?\n\nYes, the patient has a SBP of 130 mmHg and a DBP of 80 mmHg, which meets the criteria.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9447411356},{"ID":"27698_40-2022_NCT01979861","TOPIC_YEAR":2022,"RESPONSE":"#1: Is the patient female?\nYes, the patient is female.\n\n#2: Does the patient have heavy menstrual bleeding in at least 3 of the last 6 months?\nYes, the patient has prolonged oral bleeding immediately after a tooth extraction, which is consistent with heavy menstrual bleeding.\n\n#3: Does the patient have predictable cyclic menstrual cycles over the past 6 months?\nYes, the patient has a normal menstrual cycle.\n\n#4: Does the patient have excessive uterine bleeding?\nYes, the patient has prolonged oral bleeding after a tooth extraction, which is consistent with excessive uterine bleeding.\n\n#5: Is the patient premenopausal at enrollment?\nYes, the patient is premenopausal.\n\n#6: Does the patient have a normal PAP?\nNot specified in the patient note.\n\n#7: Has the patient had a previous endometrial ablation procedure?\nNo, the patient has not had a previous endometrial ablation procedure.\n\n#8: Does the patient have evidence of STI, PID, active infection of genitals, vagina, cervix, uterus, or urinary tract?\nNo, the patient does not have evidence of STI, PID, or active infection.\n\n#9: Does the patient have active endometritis or bacteremia, sepsis, or other active systemic infection?\nNo, the patient does not have active endometritis or bacteremia, sepsis, or other active systemic infection.\n\n#10: Does the patient have a known clotting defect or bleeding disorder?\nNo, the patient does not have a known clotting defect or bleeding disorder.\n\n#11: Is the patient on anticoagulant therapy?\nNo, the patient is not on anticoagulant therapy.\n\n#12: Does the patient have a hemoglobin level <8gm\/dl?\nNo, the patient does not have a hemoglobin level <8gm\/dl.\n\n#13: Has the patient had prior uterine surgery?\nNo, the patient has not had prior uterine surgery.\n\n#14: Is the patient currently on medication that could thin myometrial muscle?\nNo, the patient is not currently on medication that could thin myometrial muscle.\n\n#15: Does the patient have severe dysmenorrhea secondary to adenomyosis?\nNo, the patient does not have severe dysmenorrhea secondary to adenomyosis.\n\n#16: Does the patient have an abnormal uterine cavity?\nNo, the patient does not have an abnormal uterine cavity.\n\n#17: Does the patient have a hydrosalpinx?\nNo, the patient does not have a hydrosalpinx.\n\n#18: Is the patient currently in other clinical trial?\nNo, the patient is not currently in other clinical trial.\n\nBased on the above, the patient is eligible for the clinical trial.","PROBA":0.9636259987},{"ID":"5305_12-2021_NCT01514643","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient 18 years of age or older?\nNo, the patient is 34 years old, which is less than 18 years of age.\n\n#2: Does the patient have a radiographic evidence of tibial plateau fracture?\nNo, the patient has Marfan's syndrome and known severe mitral valve prolapse with regurgitation, but there is no mention of a tibial plateau fracture.\n\n#3: Does the patient have any history of pre-existing knee osteoarthritis based on previous diagnosis or suggestive history?\nNo, there is no mention of any history of pre-existing knee osteoarthritis.\n\n#4: Does the patient have any history of autoimmune disease?\nNo, there is no mention of any history of autoimmune disease.\n\n#5: Does the patient have any history of contralateral intra-articular knee injury?\nNo, there is no mention of any history of contralateral intra-articular knee injury.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9616439554},{"ID":"17341_36-2021_NCT03995836","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a BMI consistently > 40 kg\/m2 for 3-5 years?\nNo, the patient does not meet this criterion.\n\n#2: Does the patient have a BMI 35-40 kg\/m2 with comorbidities associated with morbid obesity (MO) susceptible to improvement with weight loss?\nYes, the patient has a BMI of 41.54 and comorbidities such as high blood pressure and dyslipidemia, which are associated with morbid obesity and are susceptible to improvement with weight loss.\n\n#3: Has the patient had more than 1 year of unsuccessful controlled medical treatment?\nYes, the patient has had more than 1 year of unsuccessful controlled medical treatment for weight loss.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9286680377},{"ID":"17334_36-2021_NCT03925610","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria of having a BMI equal or greater than 35 kg\/m2.\n\n#2: Does the patient have any exclusion criteria?\n\nYes, the patient has an exclusion criterion of being treated with opioids for chronic pain.","PROBA":0.8832647649},{"ID":"17078_36-2021_NCT01912209","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a diagnosis of three or more of the following:\n\n1. Waist circumference >=40 inches in and male and >= 35 inches in a female\n\nYes, the patient has a waist circumference of 41.54 inches, which is greater than or equal to 40 inches for males and greater than or equal to 35 inches for females, so this criterion is met.\n\n#2: Fasting triglyceride level > 150 mg\/dl\n\nYes, the patient's fasting triglyceride level is 150 mg\/dl, which is greater than 150 mg\/dl, so this criterion is met.\n\n#3: HDL-C < 40 mg\/dl in men or < 50 mg\/dl in women\n\nYes, the patient's HDL-C is 35 mg\/dl, which is less than 40 mg\/dl for males and less than 50 mg\/dl for females, so this criterion is met.\n\n#4: BP > 130\/85 mm Hg\n\nYes, the patient's BP is 130\/80 mm Hg, which is greater than 130\/85 mm Hg, so this criterion is met.\n\n#5: Fasting blood glucose > 110 mg\/dl\n\nNo, the patient's fasting blood glucose is 98 mg\/dl, which is less than 110 mg\/dl, so this criterion is not met.\n\nBased on the criteria, the patient meets three out of the five criteria for Metabolic Syndrome (waist circumference, fasting triglyceride level, and HDL-C) and does not meet the criterion for fasting blood glucose. Therefore, the patient is eligible for the clinical trial.","PROBA":0.9624668853},{"ID":"30742_65-2021_NCT02310061","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have end-stage renal disease (ESRD)?\n\nNo, the patient does not have ESRD.\n\n#2: Does the patient have a history of myocardial infarction with or without ST elevation or unstable angina, acute coronary syndrome, documented by ECG recordings and cardiac troponins, or stable angina pectoris with documented coronary artery disease by prior coronary angiography or ECG?\n\nNo, the patient does not have a history of myocardial infarction or any other form of coronary artery disease.\n\n#3: Does the patient have dyspnea class III-IV NYHA?\n\nNo, the patient does not have dyspnea class III-IV NYHA.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9545119628},{"ID":"11929_17-2022_NCT04110015","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a retinal, glaucoma, or neuro-ophthalmic disorder?\n\nNo, the patient does not have a retinal, glaucoma, or neuro-ophthalmic disorder. The patient has slowly worsening vision in both eyes, but the specific diagnosis is not mentioned in the patient note.\n\n#2: Does the patient have a normal eye exam?\n\nYes, the patient has a normal eye exam. The patient note states that the patient's pupils are normal in diameter both in the light and darkness, and the other physical examinations are normal.\n\n#3: Is the patient able to comprehend instructions and perform visual fields?\n\nYes, the patient is able to comprehend instructions and perform visual fields. The patient note does not mention any cognitive or mental health issues that would preclude the patient from participating in the study.\n\n#4: Does the patient lack a complete clinical file or a specific diagnosis?\n\nNo, the patient does not lack a complete clinical file or a specific diagnosis. The patient note provides a detailed description of the patient's symptoms and findings, and the patient has a specific diagnosis of slowly worsening vision in both eyes.\n\nBased on the above, the patient is not eligible for the clinical trial because they do not have a retinal, glaucoma, or neuro-ophthalmic disorder.","PROBA":0.9293622233},{"ID":"28060_40-2022_NCT04417400","TOPIC_YEAR":2022,"RESPONSE":"#1. Does the patient have at least one prescription medicine for a chronic condition for at least six months?\n\nNo, the patient does not have a prescription medicine for a chronic condition. The patient has prolonged oral bleeding after a tooth extraction, but this is not a chronic condition.\n\n#2. Is the patient deemed to be suitable for MUR by a pharmacist, certified to provide the MUR service?\n\nNo, the patient is not suitable for MUR because they do not have a chronic condition.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9282677248},{"ID":"33684_71-2021_NCT02503098","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nYes, the patient meets the inclusion criteria of having a clinically significant eating disorder, as evidenced by her symptoms of obesity, sleep apnea, and dissatisfaction with her body shape.\n\n#2: Does the patient meet any of the exclusion criteria?\n\nNo, the patient does not meet any of the exclusion criteria, such as having a psychiatric condition that would make participation in a clinical trial inappropriate or dangerous, or exhibiting severe suicidality.\n\nTherefore, the patient would be considered eligible for the clinical trial.","PROBA":0.9098620293},{"ID":"35784_75-2021_NCT04390867","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient implanted with a deep brain stimulation system?\nYes, the patient has an implanted deep brain stimulation system.\n\n#3: Does the patient meet the minimum improvement in motor score?\nNot specified in the patient note.\n\n#4: Does the patient have any exclusion criteria?\nNo, the patient does not have any exclusion criteria listed in the patient note.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.","PROBA":0.9108556229},{"ID":"16890_36-2021_NCT00340171","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient pregnant?\nNo, the patient is not pregnant.\n\n#2: Does the patient meet the age criteria?\nNo, the patient is 32 years old, which is outside the age range of 18-40 years.\n\n#3: Does the patient have any pregnancy complications?\nNo, the patient does not have any pregnancy complications.\n\n#4: Does the patient have accurate dating criteria?\nNo, the patient does not have accurate dating criteria (sure LMP or first trimester scan).\n\n#5: Is the patient eligible for the cross-sectional arm of the protocol?\nNo, the patient is not eligible for the cross-sectional arm of the protocol because of inaccurate dating criteria.\n\n#6: Is the patient eligible for the longitudinal arm of the protocol?\nNo, the patient is not eligible for the longitudinal arm of the protocol because of inaccurate dating criteria and the patient's age being outside the age range.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9309919394},{"ID":"16939_36-2021_NCT00664859","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have dyslipidemia?\n\nNo, the patient does not have dyslipidemia. The patient is concerned about weight concerns and has a high BMI, but there is no mention of dyslipidemia.\n\n#2: Has the patient successfully completed the double-blind study?\n\nNo, the patient is not eligible for the clinical trial because they have not completed the double-blind study.\n\n#3: Is the patient willing to abstain from medications, supplements, ingredients, and herbal therapies that were excluded in the double-blind study and continue to be excluded in the open-label study?\n\nNo, the patient is not eligible for the clinical trial because they are not willing to abstain from medications, supplements, ingredients, and herbal therapies that were excluded in the double-blind study and continue to be excluded in the open-label study.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9351187111},{"ID":"6586_15-2021_NCT00230971","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a clinical diagnosis of complicated intra-abdominal infection that requires surgery within 24 hours?\n\nYes, the patient has a clinical diagnosis of pancreatic adenocarcinoma, which is a type of cancer. Therefore, the patient is not eligible for the clinical trial.\n\n#2: Does the patient have fever plus other symptoms such as nausea, vomiting, abdominal pain?\n\nYes, the patient has fever, nausea, vomiting, and abdominal pain, which are all symptoms of complicated intra-abdominal infection.\n\nTherefore, the patient would be eligible for the clinical trial if they did not have cancer. However, since the patient has a clinical diagnosis of pancreatic adenocarcinoma, they are not eligible for the study.","PROBA":0.9311644192},{"ID":"14211_30-2021_NCT03839173","TOPIC_YEAR":2021,"RESPONSE":"#1: Birth weight\nThe patient's birth weight was 3300 grams, which is above the upper limit of the inclusion criteria (1500 grams). Therefore, the patient is not eligible for the clinical trial.\n\n#2: Gestational age\nThe patient's estimated gestational age (EGA) is not provided in the patient note. However, based on the patient's birth weight and the inclusion criteria, it is likely that the patient was not born prematurely (<33 weeks). Therefore, the patient is not eligible for the clinical trial.\n\n#3: Feeding\nThe patient is not receiving enteral feedings within 7 days of life, as the patient note states that the patient was started on Levothyroxine per day after being diagnosed with Hashimoto's thyroiditis. Therefore, the patient is not eligible for the clinical trial.\n\n#4: Breastmilk diet\nThe patient is not receiving breastmilk, as the patient note states that the patient was started on Levothyroxine per day after being diagnosed with Hashimoto's thyroiditis. Therefore, the patient is not eligible for the clinical trial.\n\nBased on the above criteria, the patient is not eligible for the clinical trial.","PROBA":0.9247192645},{"ID":"27988_40-2022_NCT03875924","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have constitutional von Willebrand disease?\n\nYes, the patient has constitutional von Willebrand disease, as indicated by the presence of prolonged oral bleeding immediately after a tooth extraction, heavy menstrual cycles, and a family history of excessive bleeding during menstrual periods.\n\n#2: Is the patient included in the research database BERHLINGO?\n\nYes, the patient is included in the research database BERHLINGO, as indicated by the presence of desmopressin administration.\n\n#3: Was the patient treated or not by desmopressin or VWF\/FVIII\/by-passing agents available on the French market at baseline?\n\nYes, the patient was treated with desmopressin, which is an VWF\/FVIII\/by-passing agent available on the French market.\n\n#4: Is the patient being followed in one of the 5 investigator HTC?\n\nYes, the patient is being followed in one of the 5 investigator HTC, as indicated by the presence of the HOPSCOTcH-WILL study.\n\n#5: Is the patient not under guardianship?\n\nYes, the patient is not under guardianship, as there is no mention of guardianship in the patient note.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9436477045},{"ID":"6872_15-2021_NCT02781012","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient over 18 years old?\nYes, the patient is over 18 years old.\n\n#2: Has the patient been recently diagnosed with pancreatic cancer (any stage)?\nYes, the patient has been recently diagnosed with pancreatic cancer (any stage).\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9053480363},{"ID":"17021_36-2021_NCT01357382","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have metabolic syndrome?\n\nYes, the patient has metabolic syndrome, as she has obesity (BMI 41.54), high blood pressure (BP 130\/80), high triglycerides (TG 150 mg\/dl), low HDL (HDL 35 mg\/dl), and high fasting glucose (FBS 98 mg\/dl).\n\n#2: Is the patient referred to the metabolic syndrome program at St. Paul's Hospital?\n\nYes, the patient is referred to the metabolic syndrome program at St. Paul's Hospital, as she is being evaluated for the ACT-OUT trial.\n\n#3: Is the patient over the age of 19?\n\nYes, the patient is over the age of 19, as she is 32 years old.\n\nTherefore, the patient is eligible for the ACT-OUT trial.","PROBA":0.9469925266}]
